OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Ocugen, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$0.79+0.01 (+0.90%)

Close on Oct 19, 2026

Market cap: $266.64M
P/E (TTM): –
Dividend yield: –

Ocugen, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	19	59	39	78	95	24	7.60	1.78	6.30	32	31	59	8.73
Short-Term Investments	–	–	0	13	0	–	–	–	0.90	–	–	–	–
Cash & Short-Term Investments	19	59	39	91	95	24	7.60	1.78	7.20	32	31	59	8.73
Prepaid Expenses & Other	5.77	3.17	3.51	7.56	7.69	1.84	1.32	0.31	0.19	0.17	0.32	0.80	–
Other Current Assets	0.44	0.88	–	–	–	–	–	0.17	0.12	0.07	0.20	0.15	–
Total Current Assets	24	62	43	98	103	26	16	1.94	8.18	32	31	59	–
Property, Plant & Equipment	14	17	17	6.05	1.16	0.63	0.22	0.25	2.72	3.86	5.21	4.88	–
Gross Property, Plant & Equipment	20	20	19	6.67	1.54	0.86	0.35	10	14	13	13	11	–
Accumulated Depreciation	-5.51	-3.16	-1.23	-0.62	-0.37	-0.23	-0.13	-10	-11	-9.39	-7.99	-6.38	–
Operating Lease Right-of-Use Assets	4.09	3.61	3.94	3.91	1.59	0.43	0.34	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	0.20	0.51	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	–	–	–	0.65	–
Other Long-Term Assets	4.47	3.90	4.29	4.09	1.80	0.71	0.67	0.12	–	–	–	–	–
Total Assets	44	82	65	109	106	27	17	2.45	11	36	37	65	–
Accounts Payable	6.20	4.24	3.17	8.06	2.31	0.40	1.90	3.28	0.78	1.59	2.02	4.89	–
Accrued Expenses	–	–	–	9.90	4.33	2.93	2.27	1.40	2.71	2.10	1.44	1.68	–
Short-Term Debt	–	–	–	–	0	0.23	0	7.48	–	–	–	–	–
Current Portion of Long-Term Debt	1.25	1.33	0	0	–	–	–	–	–	–	–	–	–
Current Debt	1.25	1.33	0	0	0	0.23	0	7.48	–	–	–	–	–
Current Portion of Leases	0.86	0.52	0.57	0.50	0.36	0.04	0.17	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	–	0.01	0.21	0.20	–	–	–	–	–
Total Current Liabilities	23	22	17	29	7.00	3.61	4.54	14	3.81	5.17	6.36	7.60	–
Long-Term Debt	28	27	2.80	2.29	1.71	1.82	1.07	1.02	–	–	–	–	–
Long-Term Leases	3.49	3.31	3.57	3.59	1.23	0.39	0.16	–	–	–	–	–	–
Operating Lease Liabilities	4.35	3.83	4.14	4.09	1.59	0.43	0.34	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	–	–	–	0.65	–
Other Long-Term Liabilities	1.60	0.56	0.53	0.24	0	0	0.01	0.04	–	–	–	–	–
Total Liabilities	56	53	24	35	9.94	5.83	5.79	15	22	23	8.59	11	–
Total Debt	29	29	2.80	2.29	1.71	2.06	1.07	8.50	–	–	–	–	–
Preferred Stock	0	0	0.00	–	5.00	0	0	0	–	–	–	–	–
Common Stock	3.13	2.92	2.57	2.22	2.00	1.84	0.53	0.05	0.16	0.16	0.13	0.13	–
Additional Paid-In Capital	393	367	324	295	226	93	62	18	197	195	194	188	–
Retained Earnings	-408	-340	-286	-223	-132	-73	-51	31	-208	-182	-166	-134	–
Treasury Stock	-0.05	-0.05	-0.05	-0.05	-0.05	-0.05	-0.05	–	–	–	–	–	–
Comprehensive Income & Other	0.06	0.05	0.02	0.03	0	–	–	0.00	–	–	–	–	–
Shareholders' Equity	-12	30	41	74	91	22	11	-13	4.43	14	28	54	-76
Total Equity	-12	30	41	74	91	22	11	-13	4.43	14	28	54	-76
Total Liabilities & Equity	44	82	65	109	106	27	17	2.45	11	36	37	65	–
Shares Outstanding(shares)	312	291	257	222	199	184	53	4.96	4.10	3.44	2.21	2.13	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -1561.4%
Net margin: -1853.9%
Return on equity, FY2025: -776.9%

Financial strength

Current ratio: 0.80
Debt to equity: -0.11
Debt to assets: 1.4%
Cash to current liabilities: 75.2%

Valuation

P/E ratio: –
Price to sales: 60.42
Price to book: –
Dividend yield: –